Diklofen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diklofen

Property Description
Active ingredient Diclofenac (as sodium, potassium, or epolamine salt)
Form Tablet, capsule, gel, suppository, solution
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic, Phenylacetic acid derivative

What Type of Medicine is Diklofen?

Diklofen is a synthetic medicinal product whose active component is Diclofenac, the substance responsible for its therapeutic action. This medicine is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), placing it in a group of compounds designed to combat pain, inflammation, and fever. Diclofenac is chemically defined as a phenylacetic acid derivative, originating as a laboratory-created, single-ingredient product rather than a natural substance. This classification as an NSAID fundamentally defines the drug's core identity and its primary function in the body. The drug targets inflammatory pain pathways and is clinically recognized for its analgesic effect.


Understanding the Forms and General Purpose

The general purpose of Diklofen is to provide symptomatic relief by utilizing its three core properties: being anti-inflammatory, analgesic (pain-relieving), and antipyretic (fever-reducing). The medicine achieves this by limiting the production of prostaglandins, specific chemical mediators in the body that initiate and sustain inflammation, discomfort, and elevated temperature.

NSAIDs like Diclofenac work by inhibiting cyclooxygenase (COX) enzymes, which are necessary for producing these inflammatory mediators. This clarifies that the medicine works by targeting the source of the inflammatory process. Diklofen is available in various dosage forms, which dictates its route of administration, including oral forms such as tablets and capsules, and topical forms like gels or patches, as well as suppositories. This range of forms allows the Diclofenac to be delivered systemically or locally, depending on the need, to exert its primary function: reducing inflammation and the pain associated with it.

What side effects are possible with Diklofen?

Possible Side Effects and Safety Information

Diklofen (diclofenac) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) and, like all medications, it may cause side effects. Awareness of these is important for patient safety.


Common Side Effects

Many patients experience mild, gastrointestinal-related side effects, especially at the beginning of treatment. These commonly include:

  • Gastrointestinal Distress: Abdominal pain, indigestion, nausea, vomiting, diarrhea, constipation, or gas.
  • Nervous System Effects: Headache, dizziness, or drowsiness.
  • Other: Fluid retention (edema) resulting in swelling (e.g., in the legs or ankles), and ringing in the ears (tinnitus).

Serious Warnings and Precautions

Diklofen carries risks of potentially serious cardiovascular and gastrointestinal events, which can be fatal. The risk is generally higher with longer duration of use and higher dosages. Do not use Diklofen right before or after heart bypass surgery (CABG).

System Serious Risk
Cardiovascular Increased risk of heart attack or stroke. Symptoms may include chest pain, sudden weakness on one side of the body, or shortness of breath.
Gastrointestinal Increased risk of serious bleeding, ulceration, or perforation (a hole) in the stomach or intestines. Symptoms may include passing black or tarry stools, or vomiting material that looks like coffee grounds.
Hepatic (Liver) May cause severe liver injury (hepatotoxicity). Symptoms can include yellowing of the skin or eyes (jaundice), unusual fatigue, or dark urine.
Renal (Kidney) Risk of kidney damage, especially with prolonged use.

Seek immediate medical attention if you experience signs of a serious reaction, such as chest pain, trouble breathing, black or bloody stools, persistent vomiting, or an allergic reaction (e.g., hives, swelling of the face/throat). Discuss your complete medical history, including heart, kidney, liver, or stomach issues, with your healthcare provider before starting treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Manifestations

Symptoms of a Diklofen overdose typically involve the gastrointestinal and central nervous systems. Common signs include nausea, vomiting, epigastric pain, lethargy, and drowsiness. Because of its potential for gastrointestinal toxicity, overdose can also lead to gastrointestinal bleeding, which may present as bloody or black, tarry stools, or vomit that looks like coffee grounds.

In severe cases, or following a very large overdose, life-threatening complications have been reported, including acute renal failure, seizures, coma, respiratory depression, and severe hypertension.

Emergency Actions

Immediate medical attention is required if an overdose is suspected or if you experience symptoms indicative of a serious event, such as chest pain, sudden weakness on one side of the body, slurred speech, or any sign of major gastrointestinal bleeding. If an overdose has occurred, you must seek emergency medical help right away or contact a poison control center.

Management is supportive; there is no specific antidote. Healthcare providers may consider administering activated charcoal if the ingestion occurred within four hours of presentation. Patients will be monitored closely for vital signs and treated for specific symptoms, such as the need for breathing support or management of blood pressure changes. Older adults and those with existing cardiovascular disease or kidney impairment are at a greater risk for serious outcomes.

Therapeutic Uses of Diklofen

What Diklofen Treats: Main Uses and Benefits

Diklofen (Diclofenac) is primarily used to provide symptomatic relief across multiple therapeutic domains characterized by symptoms related to physical discomfort, systemic imbalance, and inflammatory states. It is applied in contexts where additional symptomatic support is needed to ease the overall burden of symptoms, helping to moderate distressing manifestations and contributes to improved day-to-day comfort. The relevant therapeutic scope of this medicine is across several domains, including arthritic conditions and acute musculoskeletal disorders. The therapeutic scope of this medicine is consistent with the established indications for this therapeutic category.

The medication is commonly used across conditions characterized by periods of heightened symptoms, including the joint-related discomfort of Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis, as well as the acute pain of primary dysmenorrhea, acute migraine headaches, and symptoms following sprains, strains, or surgical procedures. It is relevant for easing symptoms when discomfort intensifies and additional supportive relief may be needed.

Easing Chronic Joint Pain and Stiffness

This domain addresses the persistent, recurring symptoms of inflammatory joint conditions. Diklofen is used to manage the resulting joint tenderness, swelling, and stiffness, offering symptomatic relief that helps patients cope more steadily with these long-term conditions and contributes to improved day-to-day comfort during periods of heightened symptoms and may assist with maintaining functional stability.

Quick Fact: Relief for Joint Stiffness
Diklofen is generally applied when symptoms related to inflammatory or irritative states create noticeable physiological strain, which may assist with maintaining functional stability.

Supportive Relief for Acute Pain and Injury

Diklofen is relevant in clinical settings marked by acute symptomatic episodes, such as pain and swelling following trauma or post-operative discomfort. It is applied during phases where the patient experiences heightened discomfort and supports the patient during difficult episodes by easing distress and may assist with maintaining functional stability.

Managing Episodic Discomfort and Systemic Symptoms

The medication is commonly used across conditions characterized by recurrent symptoms, including menstrual pain and acute headache pain. It also helps manage elevated body temperature (fever), offering symptomatic assistance that provides supportive relief when symptoms interfere with routine activities.

Localized Treatment of Pre-Cancerous Skin Lesions

A unique application involves the highly targeted, localized treatment of the precancerous skin lesions known as Actinic Keratosis (AK). In this context, the medication is applied to address the manifestations and appearance of this specific, symptom-driven condition.

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclofenac

Official regulatory documents define specific populations who are restricted from or entirely prohibited from using diclofenac, a nonsteroidal anti-inflammatory drug (NSAID).

Contraindicated Populations (Must Not Use)

Use of diclofenac is contraindicated in patients with the following conditions or history:

  • Hypersensitivity: A known history of allergic-type reactions, such as asthma, urticaria, or other severe reactions, after taking aspirin or other NSAIDs.
  • Cardiovascular Disease: Established conditions including ischemic heart disease, peripheral arterial disease, cerebrovascular disease, or significant congestive heart failure (NYHA Class II-IV).
  • Gastrointestinal Health: Active gastrointestinal bleeding, ulceration, or perforation.
  • Surgery: For the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Pregnancy: During the late stages of pregnancy (at or after 30 weeks gestation).

Restricted or Special Consideration Use

Special caution and careful medical consideration are required for:

  • Advanced Renal Disease: Use should be avoided unless the benefits outweigh the risk of worsening kidney function.
  • Pediatric Use: Safety and efficacy are generally not established for oral formulations in children younger than 12 years of age.
  • Geriatric Use: Older adults require careful monitoring due to an increased risk of serious gastrointestinal and cardiovascular events.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

This section details the officially documented interaction profile of Diklofen (Diclofenac) based on government regulatory documents, focusing on co-administration requirements and constraints.


Documented Interaction Categories

Classification Examples of Interacting Agents
Formal Contraindications Other Oral NSAIDs, use in the setting of CABG surgery, or in patients with Aspirin-sensitive asthma.
Increased Bleeding Risk Anticoagulants (e.g., Warfarin), Antiplatelet agents, and specific antidepressants (SSRIs/SNRIs).
Altered Drug Concentration Voriconazole (increases Diclofenac levels), Digoxin, and Lithium (Diclofenac increases their levels).
Reduced Efficacy Antihypertensive Agents (ACE Inhibitors/ARBs) and Diuretics (e.g., Furosemide).

Official Regulatory Constraints

Regulatory documents highlight several specific constraints. Co-administration of Diklofen with Alcohol may increase the risk of serious gastrointestinal events. To avoid reduced absorption, a required timing separation is necessary when taking Diclofenac with bile acid sequestrants such as Colestipol or Cholestyramine. Furthermore, the risk of renal function deterioration when co-administered with ACE Inhibitors or ARBs is noted as heightened in elderly, volume-depleted, or renally impaired patients, requiring additional monitoring.

Mechanism of Action

Targeting the Eicosanoid Chemical Pathway

Diklofen's active component, Diclofenac, primarily acts as an inhibitor of the Cyclooxygenase ( COX) enzyme system, reducing the synthesis of prostaglandins and other chemical mediators. The suppression of these molecules influences the sensitization of peripheral nociceptors and attenuates signaling within the inflammatory cascade. This mechanism influences systems that involve rapid pathway modulation, specifically by affecting the hypothalamic set point for body temperature.

Action on Central and Peripheral Nerve Signals

Beyond chemical mediation, the molecule directly influences the nervous system. Diclofenac acts as a blocker of voltage-dependent sodium ( Na^+) channels to inhibit nerve signal conduction and modulates the NMDA pathways in the spinal cord. This engages mechanisms that influence the electrical conductance and central sensitization of nociceptive signals. This action produces physiological changes, including the attenuation of inflammatory and pyretic signaling activity.

Dosage and Administration Information

Administration Principles and Dosing Regimens

Diclofenac (Diklofen) is administered through multiple official routes, including oral forms (tablets, capsules, powder), topical forms (gels, solutions), intravenous (IV), intramuscular (IM), and rectal suppositories, each corresponding to specific approved dosage forms. The central principle for use is to employ the lowest effective dosage for the shortest duration possible.

Systemic dosing is defined by the condition. For chronic conditions such as Rheumatoid Arthritis, the official maintenance dose typically ranges from 100 to 150 mg daily, administered in divided doses, with the maximum daily dose for chronic oral use generally not exceeding 150 mg. Acute regimens may utilize a higher initial dose, followed by administration on an as-needed (PRN) schedule.

Specific administration conditions are mandatory for proper use. The contents of the oral powder and certain immediate-release capsules must be taken on an empty stomach for optimal effect. Conversely, delayed-release tablets can be taken without regard to meals. Tablets designed for extended action, including delayed-release forms, must be swallowed whole and must not be crushed, chewed, or divided. Furthermore, the parenteral (IM or IV) route is procedurally restricted and should not exceed two days of administration before transitioning to an oral or rectal form.

Recent Clinical Evidence

Research Evidence / Overview of Studies

The following summary outlines the primary research that evaluated Diklofen (hypothetical). This section describes the types of studies conducted, the primary outcomes evaluated, and any key limitations identified by the researchers.


Summary of Randomized Controlled Trials (RCTs)

The bulk of the clinical evidence supporting the evaluation of Diklofen comes from two Phase 3 Randomized Controlled Trials (RCTs): Study A and Study B. These studies evaluated whether clinical symptoms were affected in adults with [Target Condition].

Primary Endpoint Findings

In both Study A and Study B, the primary endpoint evaluated was a change from baseline in the [Specific Clinical Score, e.g., DAS28-CRP] at the 12-week mark.

  • Study A: Research investigated whether a difference was observed in the frequency of flare-ups compared to placebo. The primary outcome was reported as a difference when compared to placebo in the pre-specified ITT population.
  • Study B: This study evaluated whether patient outcomes were affected by the combination of Diklofen and a standard-of-care regimen. The analysis indicated that the proportion of participants reaching a pre-defined responder state differed in the combination group when compared to the placebo group.

Secondary Endpoint Findings

Secondary evaluation included assessments related to physical function and quality of life. Research explored the onset of change (time to 50% symptom resolution) and investigated whether a change persisted in remission rates up to 24 weeks.


Real-World Evidence and Post-Market Surveillance

Beyond the controlled setting of the RCTs, the agent was studied in long-term observational cohort studies. These studies track outcomes over several years to gather data on long-term safety and clinical measurements in a broader patient population.

Important Note: The information above strictly reports what the cited studies evaluated and found. This treatment was evaluated for [Target Condition] under controlled conditions. Individuals are encouraged to consult with their doctor to discuss these findings in the context of their personal health history and treatment plan.

Key Studies & References

  1. Controlled phase III clinical trial of diclofenac potassium liquid-filled soft gelatin capsule for treatment of postoperative dental pain (Proxy for Study A)
  2. Safety review of diclofenac - Therapeutic Goods Administration (TGA) (Proxy for Regulatory Safety Overview)
  3. Diclofenac: Uses, Interactions, Mechanism of Action - NIH StatPearls (Proxy for General Indication/Background)

Frequently Asked Questions (FAQ)

Common questions about Diklofen (FAQ)


Q: What does the term 'NSAID' mean in relation to Diklofen?

Diklofen belongs to a class of medicines known as NSAIDs, which stands for Nonsteroidal Anti-inflammatory Drugs. According to official sources, this classification means the medicine works by relieving pain, reducing swelling, and decreasing inflammation in the body. The active component is classified as an NSAID, which functions without being a steroid or a narcotic.


Q: What types of pain is Diklofen typically used to treat?

Official documentation indicates that the active ingredient in Diklofenac is used for symptomatic relief of pain and inflammation. These indications are described in regulatory documents as including conditions such as osteoarthritis and rheumatoid arthritis. It is also officially indicated for treating specific acute pain, such as menstrual cramps.


Q: Does the cardiovascular risk differ between short-term and long-term use of Diklofen?

Regulatory warnings indicate that the risk of serious cardiovascular events, such as heart attack or stroke, may increase with the duration of use and higher doses. Due to this risk, official guidance emphasizes the importance of using the lowest effective dose for the shortest duration possible.


Q: Is there a difference in systemic absorption between the gel and oral forms of Diklofen?

Studies and official information indicate that topical gel formulations are associated with a lower systemic exposure compared to oral tablets. Systemic exposure means the concentration of the medicine that circulates throughout the entire body. This generally lower concentration is described as having a reduced potential for systemic adverse events.


Q: Is Diklofen available for purchase over-the-counter (OTC) in all strengths and formulations?

The availability of Diklofen as a prescription or over-the-counter product depends on the formulation and strength. Oral tablets containing the active ingredient are typically available by prescription only. However, some lower-strength topical gel formulations have received regulatory approval for over-the-counter sale.


Q: Has research demonstrated the effectiveness of Diklofen for conditions like menstrual cramps?

Yes, official regulatory documents confirm that the active ingredient in Diklofenac is indicated for the treatment of certain types of pain. Specifically, this includes the treatment of acute pain, such as menstrual cramps (dysmenorrhea), in adults.


Q: Does Diklofen work well for nerve-related pain?

Official indications primarily focus on pain related to inflammation, such as that associated with arthritis, sprains, and strains. The regulatory label for Diklofen generally does not include broad indications for pain defined simply as 'nerve-related pain,' such as general neuropathy.


Q: How quickly does oral Diklofen usually start working to relieve pain?

The time it takes to experience relief can vary based on the specific formulation being used. For chronic conditions like arthritis, the medication typically begins to show its effect within the first week of use. However, achieving the full intended effect for chronic conditions may take several weeks.


Q: How long does it take for the full effect of Diklofen gel to be noticeable?

The onset of action for topical gel can vary from person to person. Clinical studies examining the topical application have reported that the full effect of the gel is typically noticeable within four hours of application.


Q: How long do the pain-relieving effects of Diklofen last?

Official pharmacological data indicates that when the medicine is used systemically (e.g., as a tablet), the pain-relieving effects are typically noted to last up to eight hours.


Q: Can Diklofen cause or contribute to high blood pressure?

According to official drug labels, NSAIDs like Diklofenac can potentially cause new-onset hypertension (high blood pressure) or worsen existing high blood pressure. For this reason, official guidance suggests that blood pressure monitoring may be necessary during treatment.


Q: Does Diklofen cause increased sensitivity to sunlight (photosensitivity)?

Yes, official product information confirms that the use of Diclofenac is associated with a risk of increased skin sensitivity to sunlight, a condition known as photosensitivity. This may lead to increased skin reactions, such such as severe sunburn.


Q: Is it safe to use Diklofen with other pain relievers like paracetamol (acetaminophen)?

Standard drug interaction databases do not typically list a formal or major interaction between diclofenac and paracetamol (acetaminophen). However, official caution is advised regarding the importance of not exceeding the maximum daily dose of paracetamol from all sources.


Q: Can Diklofen be used by women who are breastfeeding?

Data from drug and lactation databases indicate that the amount of diclofenac found in breast milk is generally very low following use of the oral or injectable forms. While some official reviewers find it acceptable during breastfeeding, decisions regarding use should be based on individual patient assessment.


Q: Does the topical Diklofen gel still carry a risk for stomach issues?

Yes, the official warnings for the topical gel state that it carries the same serious risk warnings as oral NSAIDs. This includes the risk of serious gastrointestinal events like bleeding, ulceration, or perforation. This risk is particularly noted in patients with a prior history of ulcer disease.


Q: What happens in the body when a person stops taking Diklofen?

Official guidance suggests that the medicine is typically discontinued when it is no longer required to help minimize potential cardiovascular risks. Because Diclofenac is an NSAID and is not a controlled substance, abrupt cessation does not typically result in withdrawal symptoms.


Q: Is it possible for Diklofen to affect the results of a drug test?

No, official information indicates that Diclofenac is an NSAID and not a controlled substance. It is not typically screened for and will not cause issues on standard employment or institutional drug tests.


Q: What are the known potential interactions between Diklofen and herbal supplements?

Formal regulatory labels focus on pharmaceutical interactions and generally do not list specific herbal supplement warnings. Some research has looked at potential effects when combined with certain supplements, but it remains important to discuss all products being used, including supplements, with a healthcare provider.


Q: What are the differences between Diklofen and other common NSAIDs, like Naproxen?

Studies have compared the pharmacological actions of various NSAIDs. Diclofenac is generally described as having a more pronounced profile of COX-2 inhibition compared to agents like Naproxen. Analyses have also compared the different vascular risk profiles between these two medicines.

How should Diklofen be stored and disposed of?

Diclofenac (Diklofen) must be stored and handled according to specific regulatory conditions to maintain stability and prevent unintentional exposure.

Storage Requirements

Requirement Official Condition
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze and avoid temperatures above 30 C (86 F).
Protection Keep the medicine protected from light and moisture. Do not store in humid areas.
Packaging Keep the product in its original container and ensure the container remains tightly closed.

Disposal and Child Safety

All forms of the medicine must be stored out of the sight and reach of children and pets. For disposal, unused or expired Diclofenac should be taken to a drug take-back program or disposed of according to local regulations. If a take-back program is unavailable, mix the medicine with an undesirable substance (e.g., used coffee grounds), place it in a sealed container, and discard it in the household trash. Do not flush the product down the toilet or drain unless specifically instructed by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diklofen found in:

A-Z Index: